Kyungin Synthetic Balance Sheet Health
Financial Health criteria checks 2/6
Kyungin Synthetic has a total shareholder equity of ₩261.0B and total debt of ₩237.1B, which brings its debt-to-equity ratio to 90.8%. Its total assets and total liabilities are ₩559.4B and ₩298.4B respectively. Kyungin Synthetic's EBIT is ₩13.4B making its interest coverage ratio 1.5. It has cash and short-term investments of ₩51.3B.
Key information
90.8%
Debt to equity ratio
₩237.06b
Debt
Interest coverage ratio | 1.5x |
Cash | ₩51.27b |
Equity | ₩260.97b |
Total liabilities | ₩298.42b |
Total assets | ₩559.38b |
Recent financial health updates
Kyungin Synthetic (KRX:012610) Seems To Be Using A Lot Of Debt
Aug 07Is Kyungin Synthetic (KRX:012610) A Risky Investment?
May 04Is Kyungin Synthetic (KRX:012610) Using Too Much Debt?
Jan 05Recent updates
Kyungin Synthetic (KRX:012610) Seems To Be Using A Lot Of Debt
Aug 07Is Kyungin Synthetic (KRX:012610) A Risky Investment?
May 04Kyungin Synthetic Co., Ltd.'s (KRX:012610) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 09Should Kyungin Synthetic Co., Ltd. (KRX:012610) Be Part Of Your Income Portfolio?
Feb 16What Can The Trends At Kyungin Synthetic (KRX:012610) Tell Us About Their Returns?
Jan 26Is Kyungin Synthetic (KRX:012610) Using Too Much Debt?
Jan 05Investors Who Bought Kyungin Synthetic (KRX:012610) Shares Five Years Ago Are Now Up 112%
Dec 15Kyungin Synthetic Co., Ltd.'s (KRX:012610) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 24Financial Position Analysis
Short Term Liabilities: A012610's short term assets (₩280.9B) exceed its short term liabilities (₩256.9B).
Long Term Liabilities: A012610's short term assets (₩280.9B) exceed its long term liabilities (₩41.5B).
Debt to Equity History and Analysis
Debt Level: A012610's net debt to equity ratio (71.2%) is considered high.
Reducing Debt: A012610's debt to equity ratio has increased from 73.6% to 90.8% over the past 5 years.
Debt Coverage: A012610's debt is not well covered by operating cash flow (18.7%).
Interest Coverage: A012610's interest payments on its debt are not well covered by EBIT (1.5x coverage).